Growth factor which acts through ErbB-4 RTK

Details Growth factor which acts through ErbB-4 RTK Growth factor which acts through ErbB-4 RTK

2011-07-19

2011-07-19

Kemmerer, Elizabeth C (Department: 1646)

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

C530S324000, C530S350000

Reexamination Certificate

active

07981997

ABSTRACT:
The present invention provides for isolated polypeptides capable of binding ErbB-4.

REFERENCES:
patent: 4474893 (1984-10-01), Reading
patent: 5350836 (1994-09-01), Kopchick et al.
patent: 5356775 (1994-10-01), Hebert et al.
patent: 5585089 (1996-12-01), Queen et al.
patent: 6544759 (2003-04-01), Harari et al.
patent: 6825333 (2004-11-01), Kavanaugh et al.
patent: 7094882 (2006-08-01), Harari et al.
patent: 2004/0121326 (2004-06-01), Harari et al.
patent: 2007/0015196 (2007-01-01), Harari et al.
patent: WO 98/50071 (1998-11-01), None
patent: WO 98/50556 (1998-11-01), None
patent: WO 99/07870 (1999-02-01), None
patent: WO 99/11813 (1999-03-01), None
patent: WO 99/19489 (1999-04-01), None
patent: WO 99/33962 (1999-07-01), None
patent: WO 00/39302 (2000-07-01), None
patent: WO 00/71574 (2000-11-01), None
patent: WO 01/14415 (2001-03-01), None
patent: WO 01/81540 (2001-11-01), None
Harari et al., Oncogene, Apr. 29, 1999, vol. 18(17):2681-2689.
Official Action Dated Nov. 3, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/492,124.
Official Action Dated May 12, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/492,124.
Official Action Dated Jun. 27, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/492,124.
Response Dated Feb. 2, 2009 of Official Action of Nov. 3, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/492,124.
Alimandi et al. “Epidermal Growth Factor and Betacellulin Mediate Signal Transduction Through Co-Expressed ErbB2 and ErbB3 Receptors”, EMBO J., 15; 16(18): 5608-5617, 1997.
Barbacci et al. “The Structural Basis for the Specificity of Epidermal Growth Factor and Heregulin Binding”, J. Biol. Chem., 270(16): 9585-9589, 1995. Erratum in: J. Biol. Chem., 270(47): 28494, 1995.
Ben-Baruch et al. “Neu Differentiation Factors: A Family of Alternatively Spliced Neuronal and Mesenchymal Factors”, Proc. Soc. Exp. Biol. Med., 206(3): 221-227, 1994.
Burden et al. “Neuregulins and Their Receptors: A Versatile Signaling Module in Organogenesis and Oncogenesis”, Neuron, 18(6): 847-855, 1997.
Caraway III et al. “Neuregulin-2, A New Ligand of ErbB3/ErbB4-Receptor Tyrosine Kinases”, Nature, 387: 512-516, 1997.
Chang et al. “Ligands for ErbB-Family Receptors Encoded by A Neuregulin-Like Gene”, Nature, 387: 509-512, 1997.
Chang et al. “The Expression of Type I Growth Factor Receptors in the Squamous Neoplastic Changes of Uterine Cervix”, J. Biomed. Sci., 8(2): 206-213, 2001.
Chen et al. “An Immunological Approach Reveals Biological Differences Between the Two NDF/Heregulin Receptors, ErbB-3 and ErbB-4”, J. Biol. Chem., 271(13): 7620-2629, 1996.
Cohen et al. “The Relationship Between Human Epidermal Growth-Like Factor Receptor Expression and Cellular Transformation in NIH3T3 Cells”, J. Biol. Chem., 271(48): 30897-30903, 1996.
Di Fiore et al. “A Single Amino Acid Substitution Is Sufficient to Modify the Mitogenic Properties of the Epidermal Growth Factor Receptor to Resemble That of GP185erbB-2”, The EMBO Journal, 11(11): 3927-3933, 1992.
Elenius et al. “Activation of HER4 by Heparin-Binding EGF-Like Growth Factor Stimulates Chemotaxis But Not Proliferation”, EMBO J., 16(6): 1268-1278, 1997.
Gassman et al. “Aberrant Neural and Cardiac Development in Mice Lacking the ErbB4 Neuregulin Receptor”, Nature, 378: 390-395, 1995.
Gilbertson et al. “Expression of the ErbB-Neuregulin Signaling Network During Human Cerebellar Development: Implications for the Biology of Medulloblastoma”, Cancer Res., 58(17): 3932-3941, 1998. Abstract.
Gilbertson et al. “Prognostic Significance of HER2 and HER4 Coexpression in Childhood Medulloblastoma”, Cancer Res. 57(15): 3272-3280, 1997. Abstract.
Gilmour et al. “Expression of ErbB-4/HER-4 Growth Factor Receptor Isoforms in Ovarian Cancer”, Cancer Res., 61(5): 2169-2176, 2001.
Graber et al. “ErbB-4 mRNA Expression Is Decreased in Non-Metastatic Pancreatic Cancer”, Int. J. Cancer, 84(1): 24-27, 1999.
Harari et al. “Neuregulin-4: A Novel Growth Factor That Acts Through the ErbB-4 Receptor Tyrosine Kinase”, Oncogene, 18: 2681-2689, 1999.
Hayes et al. “Identification and Characterization of Novel Spliced Variants of Neuregulin 4 in Prostate Cancer”, Clinical Cancer Research, 13(11): 3147-3155, Jun. 1, 2007.
Higashiyama et al. “A Heparin-Binding Growth Factor Secreted by Macrophage-Like Cells That Is Related to EGF”, Science, 251: 936-939, 1991.
Higashiyama et al. “A Novel Brain-Derived Member of the Epidermal Growth Factor Family That Interacts With ErbB3 and ErbB4”, J. Biochem., 122(3): 675-680, 1997.
Holmes et al. “Identification of Heregulin, A Specific Activator of P185ErbB2”, Science, 256(5060): 1205-1210, 1992.
Ibrahim et al. “Expression of c-erbB Proto-Oncogene Family Members in Squamous Cell Carcinoma of the Head and Neck”, Anticancer Res., 17(6D): 4539-4546, 1997. Abstract.
Jones et al. “Binding Interaction of the Heregulinbeta EGF Domain With ErbB3 and ErbB4 Receptors Assessed by Alanine Scanning Mutagenesis”, J. Biol. Chem., 273(19): 11667-11674, 1998.
Karunagaran et al. “ErbB-2 Is A Common Auxiliary Subunit of NDF and EGF Receptors: Implications for Breast Cancer”, EMBO J., 15(2): 254-264, 1996.
Klapper et al. “Biochemical and Clinical Implications of the ErbB/HER Signal Network of Growth Factor Receptors”, Adv. Cancer Res., 7: 25-79, 2000. Abstract.
Krahn et al. “Coexpression Patterns of EGFR, HER2, HER3 and HER4 in Non-Melanoma Skin Cancer”, Eur. J. Cancer, 37(2): 251-259, 2001. Abstract.
Kritzik et al. “Expression of ErbB Receptors During Pancreatic Islet Development and Regrowth”, J. Endocrinol., 165(1): 67-77, 2000.
Lee et al. “Requirement for Neuregulin Receptors ErbB2 in Neural and Cardiac Development”, Nature, 378: 394-398, 1995.
Lin et al. “Synthesis of A Biological Active Tumor Growth Factor From the Predicted DNA Sequence of Shope Fibroma Virus”, Biochemistry, 27(15): 5640-5645, 1988.
Lyne et al. “Tissue Expression of Neu Differentiation Factor/Heregulin and Its Receptor Complex in Prostate Cancer and Its Biologic Effects on Prostate Cancer Cells In Vitro”, Cancer J. Sci. Am., 3(1): 21-30, 1997. Abstract.
Marchionni et al. “Glial Growth Factors Are Alternatively Spliced ErbB2 Ligands Expressed in the Nervous System”, Nature, 362: 312-318, 1993.
Marquardt et al. “Rat Transforming Growth Factor Type 1: Structure and Relation to Epidermal Growth Factor”, Science, 223: 1079-1082, 1984.
Memon et al. “Expression of HER3, HER4, and Their Ligand Heregulin-4 Is Associated With Better Survival in Bladder Cancer Patients”, British Journal of Cancer, 91: 2034-2041, 2004.
Meyer et al. “Multiple Essential Functions of Neuregulin in Development”, Nature, 378: 386-390, 1995. Erratum in: Nature, 378: 753, 1995.
Olayioye et al. “The ErbB Signaling Network: Receptor Heterodimerization in Development and Cancer”, The EMBO Journal, 19(13): 3159-3167, 2000.
Ozawa et al. “Growth Factors and Their Receptors in Pancreatic Cancer”, Teratog. Carcinog. Mutagen., 21(1): 27-44, 2001.
Peles et al. “Isolation of the Neu/HER-2 Stimulatory Ligand: A 44 Kd Glycoprotein That Induces Differentiation of Mammary Tumor Cells”, Cell, 69(1): 205-216, 1992.
Pinkas-Kramarski et al. “ErbB Tyrosine Kinases and the Two Neuregulin Families Constitute A Ligand-Receptor Network”, Mol. Cell Biol., 19(12): 86-95, 1999.
Révillion et al. “ErbB/HER Ligands in Human Breast Cancer, and Relationship With Their Receptors, the Bio-Pathological Features and Prognosis”, Annals of Oncology, 19: 73-80, 2008.
Ricci et al. “Expression of HER/ErbB Family of Receptor Tyrosine Kinases and Induct

Affiliated with

Also associated with

Rating

Growth factor which acts through ErbB-4 RTK does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Growth factor which acts through ErbB-4 RTK, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Growth factor which acts through ErbB-4 RTK will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2693384